Results 121 to 130 of about 12,555 (220)

Exploratory Analysis of Gut Microbiome and Metabolic Profile Changes Following Lenvatinib and Anti-PD-1 Combination Therapy in Liver Cancer. [PDF]

Metabolites
Zhong R, Lin Z, Jin B, Wang X, Mu H, Hu J, Li Q, Dou P, Liu X, Hu C, Xu G, Tan G.   +11 more
europepmc   +1 more source

Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma. [PDF]

JHEP Rep
Klug JH, Aliraj B, Alcober-Boquet L, Denk D, Germann L, Meindl-Beinker NM, De La Torre C, Waidmann O, Finkelmeier F, Zeuzem S, Brüne B, Vogl TJ, Weigert A, Piiper A.   +13 more
europepmc   +1 more source

Targeting STE20-type kinase MST3 improves metabolic dysfunction-associated steatohepatitis without affecting hepatocellular carcinoma development in mice. [PDF]

BMC Med
Zhang J, Gongye X, Kovooru L, Andersson E, Asiedu B, Amrutkar M, Gul N, Myers C, Booten S, Lind DE, Xia Y, Molinaro A, Härtlova A, Lindahl P, Murray S, Mahlapuu M.   +15 more
europepmc   +1 more source

Ameliorative effect of Inula racemosa Hook. F root extract against diethylnitrosamine induced hepatic damage in murine model. [PDF]

J Ayurveda Integr Med
Jamwal S, Kumar R, Asrani RK, Ankita, Verma A, Bisht E, Katoch S, Patial V, Sharma V, Kumar A, Patil RD.   +10 more
europepmc   +1 more source

Sex disparity in liver cancer recurrence-from bench to bedside. [PDF]

Hepatobiliary Surg Nutr
Yamada T, Uehara K, Yoshida H.
europepmc   +1 more source

Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies. [PDF]

Cancers (Basel)
Singla RK, Bishayee A.
europepmc   +1 more source

Adipose-derived stem cell extracellular vesicles attenuate liver fibrosis via restoration of gut barrier function and modulation of gut microbiota. [PDF]

Extracell Vesicles Circ Nucl Acids
Wu B, Guo J, Wang J, Feng J, Xu J.
europepmc   +1 more source

UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesis. [PDF]

Redox Biol
Liang Q, Xu S, Fang Y, Wang X, Xiao Y, Wang Y, Li S, Guo Q, Cao Y, Cao Y, Liu C, Zhao Y, Luo Y, Wu A, Wang M, Shi J, Li G, Cong YS.   +17 more
europepmc   +1 more source

Lisosan G as a Modulator of Serum Lipid/Lipoprotein Changes, Lipid Metabolism and TGF-β1 Level in Neoplastic and Non-Neoplastic Liver Injury: A Rat Model Study. [PDF]

Biology (Basel)
Szymczak B, Pozzo L, Zmorzyński S, Wilczyńska A, Vornoli A, Lutnicka M, Wójcik M.   +6 more
europepmc   +1 more source